- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04506502
Functional Change With MMS (FMS)
August 6, 2020 updated by: Zeltiq Aesthetics
Functional Changes With Magnetic Muscle Stimulation of Abdominal Muscle
Evaluate the safety and efficacy of magnetic muscle stimulation (MMS) of abdominal muscle.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Pleasanton, California, United States, 94588
- Innovation Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
22 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria
- Subject (healthy volunteer) has read and signed the study written informed consent form.
- Male or female ≥ 22 years and ≤65 years of age.
- Subject has not had weight change exceeding 5% of body weight in the preceding month.
- Subject agrees to maintain body weight within 5% during the study by not making any changes in diet or exercise routine during the course of the study.
- Subject has a BMI ≤ 30 as determined at screening.
- Subject agrees to have photographs taken of the treatment area(s) during the scheduled time periods.
- Subject agrees to refrain from any new abdominal muscle training exercises of the treatment area during the course of the study.
Exclusion Criteria
- Subject has had a recent surgical procedure(s) in the area of intended treatment and muscle contractions may disrupt the healing process.
- Subject needs to administer or has a known history of subcutaneous injections into the area of intended treatment (e.g., heparin, insulin) within the past month.
- Subject has had an intrauterine contraceptive device inserted or removed within the past month.
- Subject has a bleeding disorder or hemorrhagic condition
- Subject is taking or has taken diet pills or supplements within the past month.
- Subject has an active implanted electrical device such as a cardiac pacemaker, cochlear implant, intrathecal pump, hearing aids, defibrillator, or drug delivery system.
- Subject has metal or electronic implants in or adjacent to the treatment area
- Subject has an abdominal hernia.
- Subject has pulmonary insufficiency.
- Subject has a cardiac disorder.
- Subject has a malignant tumor.
- Subject has been diagnosed with a seizure disorder such as epilepsy.
- Subject currently has a fever.
- Subject is diagnosed with Grave's disease.
- Subject has a growth plate in the treatment area
- Subject is pregnant or intending to become pregnant during the study period (in the next 9 months).
- Subject is lactating or has been lactating in the past 6 months.
- Subject is unable or unwilling to comply with the study requirements.
- Subject is currently enrolled in a clinical study of any unapproved investigational device, investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study.
- Any other condition or laboratory value that would, in the professional opinion of the Investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Muscle Toning
The treatments are designed to evaluate muscle toning, firming and strengthening in the abdomen and buttocks.
|
The MMS device will be used to perform the treatments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Satisfaction Scale (BSS)
Time Frame: 4-wk follow up visit
|
Change in subject perception of body shape using the Body Satisfaction Scale (BSS) at the 4-Week follow-up visit.
|
4-wk follow up visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kerrie Jiang, NP, Zeltiq Aesthetics
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 3, 2020
Primary Completion (Anticipated)
May 1, 2021
Study Completion (Anticipated)
May 1, 2022
Study Registration Dates
First Submitted
August 6, 2020
First Submitted That Met QC Criteria
August 6, 2020
First Posted (Actual)
August 10, 2020
Study Record Updates
Last Update Posted (Actual)
August 10, 2020
Last Update Submitted That Met QC Criteria
August 6, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZA19-003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Weakness
-
St. Luke's-Roosevelt Hospital CenterCompletedFall Risk | Quadriceps Muscle Weakness | Adductor Muscle WeaknessUnited States
-
Association Pro-arteActive, not recruitingWeakness, Muscle | AmyotrophiaFrance
-
University of Central ArkansasCompletedPelvic Floor Muscle WeaknessUnited States
-
Ludwig Boltzmann Institute of Electrical Stimulation...Medical University of Vienna; European Union; Comenius University; Ministry of...CompletedMuscle Weakness Condition | Therapy EffectAustria, Slovakia
-
Rutgers, The State University of New JerseyRecruitingPhysical Disability | Muscle Atrophy or Weakness | Muscle Loss | Physical Inactivity | Delirium in Old Age | Hospital Acquired Condition | Weakness, MuscleUnited States
-
University of MilanCompleted
-
University of Texas Southwestern Medical CenterTerminatedMuscle Cramp | Statin Adverse Reaction | Weakness, Muscle | AcheUnited States
-
Riphah International UniversityCompletedMuscle Weakness ConditionPakistan
-
University of Central FloridaCompletedMuscle Weakness | Muscle Atrophy | Muscle Loss | Weakness, Muscle | Injury, KneeUnited States
-
Ahram Canadian UniversityRecruiting
Clinical Trials on The ZELTIQ System
-
Zeltiq AestheticsActive, not recruiting
-
Zeltiq AestheticsUnknown
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsUnknown
-
Zeltiq AestheticsCompleted